IL161409A0 - Methods for ligand discovery - Google Patents
Methods for ligand discoveryInfo
- Publication number
- IL161409A0 IL161409A0 IL16140902A IL16140902A IL161409A0 IL 161409 A0 IL161409 A0 IL 161409A0 IL 16140902 A IL16140902 A IL 16140902A IL 16140902 A IL16140902 A IL 16140902A IL 161409 A0 IL161409 A0 IL 161409A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- ligand discovery
- ligand
- discovery
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B20/00—Methods specially adapted for identifying library members
- C40B20/08—Direct analysis of the library members per se by physical methods, e.g. spectroscopy
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/990,421 US6919178B2 (en) | 2000-11-21 | 2001-11-21 | Extended tethering approach for rapid identification of ligands |
| US10/121,216 US6998233B2 (en) | 1998-06-26 | 2002-04-10 | Methods for ligand discovery |
| PCT/US2002/013061 WO2003046200A2 (en) | 2001-11-21 | 2002-04-24 | Methods for ligand discovery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161409A0 true IL161409A0 (en) | 2004-09-27 |
Family
ID=26819229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16140902A IL161409A0 (en) | 2001-11-21 | 2002-04-24 | Methods for ligand discovery |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050142614A1 (https=) |
| EP (2) | EP1939625A3 (https=) |
| JP (3) | JP4391237B2 (https=) |
| AU (2) | AU2002254725A1 (https=) |
| CA (1) | CA2464094C (https=) |
| IL (1) | IL161409A0 (https=) |
| MX (1) | MXPA04004814A (https=) |
| NZ (1) | NZ532579A (https=) |
| RU (1) | RU2295518C2 (https=) |
| WO (1) | WO2003046200A2 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214487B2 (en) | 1998-06-26 | 2007-05-08 | Sunesis Pharmaceuticals, Inc. | Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates |
| US6335155B1 (en) * | 1998-06-26 | 2002-01-01 | Sunesis Pharmaceuticals, Inc. | Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules |
| US6919178B2 (en) * | 2000-11-21 | 2005-07-19 | Sunesis Pharmaceuticals, Inc. | Extended tethering approach for rapid identification of ligands |
| WO2003081210A2 (en) | 2002-03-21 | 2003-10-02 | Sunesis Pharmaceuticals, Inc. | Identification of kinase inhibitors |
| AR054181A1 (es) * | 2004-08-26 | 2007-06-06 | Nicholas Piramal India Ltd | Prodrogas que contienen enlaces bio-divisibles. composiiciones farmaceuticas |
| BRPI0622054B8 (pt) | 2006-09-22 | 2021-05-25 | Oxford Amherst Llc | composto e composição farmacêutica |
| IL295053A (en) * | 2007-03-28 | 2022-09-01 | Pharmacyclics Llc | Broton tyrosine kinase inhibitors |
| US20120101114A1 (en) | 2007-03-28 | 2012-04-26 | Pharmacyclics, Inc. | Inhibitors of bruton's tyrosine kinase |
| ES2660418T3 (es) | 2008-07-16 | 2018-03-22 | Pharmacyclics Llc | Inhibidores de la tirosina quinasa de Bruton para el tratamiento de tumores sólidos |
| JP2012501654A (ja) * | 2008-09-05 | 2012-01-26 | アビラ セラピューティクス， インコーポレイテッド | 不可逆的インヒビターの設計のためのアルゴリズム |
| NZ620174A (en) | 2009-09-16 | 2016-08-26 | Celgene Avilomics Res Inc | Protein kinase conjugates and inhibitors |
| EP2519664A4 (en) | 2009-12-30 | 2014-03-12 | Avila Therapeutics Inc | LIGAND-RELATED COVALENTS MODIFYING A PROTEIN |
| US8859731B2 (en) | 2010-04-21 | 2014-10-14 | Novo Nordisk A/S | Selective modification of proteins |
| CN107898791A (zh) | 2010-06-03 | 2018-04-13 | 药品循环有限责任公司 | 布鲁顿酪氨酸激酶(btk)抑制剂的应用 |
| US9138436B2 (en) | 2011-07-13 | 2015-09-22 | Pharmacyclics Llc | Inhibitors of Bruton's tyrosine kinase |
| US8377946B1 (en) | 2011-12-30 | 2013-02-19 | Pharmacyclics, Inc. | Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
| JO3754B1 (ar) | 2012-06-04 | 2021-01-31 | Pharmacyclics Llc | أشكال كريستالين لمثبط أنزيم كيناز تيروسين بروتون |
| CN104704129A (zh) | 2012-07-24 | 2015-06-10 | 药品循环公司 | 与对布鲁顿酪氨酸激酶(btk)抑制剂的抗性相关的突变 |
| EA201590855A1 (ru) | 2012-11-15 | 2015-11-30 | Фармасайкликс, Инк. | Соединения пирролопиримидина как ингибиторы киназ |
| CA2919996A1 (en) | 2013-08-02 | 2015-02-05 | Pharmacyclics Llc | Methods for the treatment of solid tumors |
| US9415050B2 (en) | 2013-08-12 | 2016-08-16 | Pharmacyclics Llc | Methods for the treatment of HER2 amplified cancer |
| CA2925124A1 (en) | 2013-09-30 | 2015-04-02 | Pharmacyclics Llc | Inhibitors of bruton's tyrosine kinase |
| WO2015143400A1 (en) | 2014-03-20 | 2015-09-24 | Pharmacyclics, Inc. | Phospholipase c gamma 2 and resistance associated mutations |
| AU2015296215A1 (en) | 2014-08-01 | 2017-03-23 | Pharmacyclics Llc | Inhibitors of bruton's tyrosine kinase |
| SG11201700849XA (en) | 2014-08-07 | 2017-03-30 | Pharmacyclics Llc | Novel formulations of a bruton's tyrosine kinase inhibitor |
| IL315294A (en) | 2015-03-03 | 2024-10-01 | Pharmacyclics Llc | Pharmaceutical formulations of bruton's tyrosine kinase inhibitor |
| JP7697280B2 (ja) * | 2021-06-15 | 2025-06-24 | 株式会社オートネットワーク技術研究所 | 車載制御装置、イーサネットスイッチおよび機器設定方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5367058A (en) * | 1993-08-25 | 1994-11-22 | Becton, Dickinson And Company | Modified antibodies with increased affinity |
| US5361058A (en) * | 1993-11-02 | 1994-11-01 | Gould Electronics Inc. | Time delay fuse |
| DE19610103A1 (de) * | 1996-03-15 | 1997-09-18 | Basf Ag | Cycloalkylderivate und ihre Synthese an fester Phase |
| WO1999041216A1 (en) * | 1998-02-17 | 1999-08-19 | Chembridge Corporation | Supports for solid state chemical reactions and method of use thereof |
| US6344330B1 (en) * | 1998-03-27 | 2002-02-05 | The Regents Of The University Of California | Pharmacophore recombination for the identification of small molecule drug lead compounds |
| AU2573102A (en) * | 2000-11-21 | 2002-06-03 | Sunesis Pharmaceuticals Inc | An extended tethering approach for rapid identification of ligands |
-
2002
- 2002-04-24 CA CA2464094A patent/CA2464094C/en not_active Expired - Fee Related
- 2002-04-24 NZ NZ532579A patent/NZ532579A/en not_active IP Right Cessation
- 2002-04-24 EP EP08006555A patent/EP1939625A3/en not_active Withdrawn
- 2002-04-24 JP JP2003547631A patent/JP4391237B2/ja not_active Expired - Fee Related
- 2002-04-24 EP EP02723967A patent/EP1446496A4/en not_active Withdrawn
- 2002-04-24 AU AU2002254725A patent/AU2002254725A1/en not_active Abandoned
- 2002-04-24 RU RU2004119036/04A patent/RU2295518C2/ru not_active IP Right Cessation
- 2002-04-24 IL IL16140902A patent/IL161409A0/xx unknown
- 2002-04-24 WO PCT/US2002/013061 patent/WO2003046200A2/en not_active Ceased
- 2002-04-24 MX MXPA04004814A patent/MXPA04004814A/es active IP Right Grant
-
2005
- 2005-02-09 US US11/054,754 patent/US20050142614A1/en not_active Abandoned
-
2009
- 2009-01-30 JP JP2009020721A patent/JP2009109515A/ja not_active Withdrawn
- 2009-07-22 AU AU2009202965A patent/AU2009202965A1/en not_active Abandoned
-
2011
- 2011-02-25 JP JP2011040912A patent/JP2011140497A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005510574A (ja) | 2005-04-21 |
| US20050142614A1 (en) | 2005-06-30 |
| CA2464094C (en) | 2013-07-02 |
| AU2002254725A1 (en) | 2003-06-10 |
| JP2009109515A (ja) | 2009-05-21 |
| EP1446496A2 (en) | 2004-08-18 |
| EP1939625A3 (en) | 2008-09-03 |
| JP2011140497A (ja) | 2011-07-21 |
| NZ532579A (en) | 2006-11-30 |
| WO2003046200A3 (en) | 2003-07-24 |
| CA2464094A1 (en) | 2003-06-05 |
| WO2003046200A2 (en) | 2003-06-05 |
| EP1939625A2 (en) | 2008-07-02 |
| AU2009202965A1 (en) | 2009-08-13 |
| JP4391237B2 (ja) | 2009-12-24 |
| RU2295518C2 (ru) | 2007-03-20 |
| EP1446496A4 (en) | 2005-03-30 |
| MXPA04004814A (es) | 2004-08-11 |
| RU2004119036A (ru) | 2005-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL161409A0 (en) | Methods for ligand discovery | |
| AU2002349297A8 (en) | Statin-like compounds | |
| GB0101996D0 (en) | Organtic compounds | |
| GB0102668D0 (en) | Compounds | |
| IL162242A0 (en) | Azaindolylalkylamine derivatives as5-hydroxytryptamine-6 ligands | |
| GB0112324D0 (en) | Compounds | |
| GB0108475D0 (en) | New compounds | |
| GB0102665D0 (en) | Compounds | |
| GB0108102D0 (en) | Compounds | |
| GB0102673D0 (en) | Compounds | |
| GB0119472D0 (en) | Compounds | |
| GB0115841D0 (en) | Ligand | |
| GB0118364D0 (en) | Compounds | |
| GB0115178D0 (en) | Compounds | |
| GB0119473D0 (en) | Compounds | |
| GB0108097D0 (en) | Compounds | |
| GB0105098D0 (en) | Compounds | |
| GB0114144D0 (en) | Location discovery | |
| GB0102417D0 (en) | Location Discovery | |
| AU2001278758A1 (en) | Ligands | |
| HU0103282D0 (en) | Round-sewing-machine for haemorrhoidectomy | |
| HUP0102279D0 (en) | New compounds | |
| GB0117780D0 (en) | New compounds | |
| GB0100265D0 (en) | Diphosphine compounds and methods for their preparation | |
| GB0104397D0 (en) | Compounds |